Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Overall Survival”

386 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 386 results

Not applicableStudy completedNCT02392078
What this trial is testing

Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System

Who this might be right for
Metastatic Brain TumorPrimary Brain TumorEpileptic/Seizure Foci+1 more
Monteris Medical 1,153
Large-scale testing (Phase 3)Ended earlyNCT02470585
What this trial is testing

Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Adults With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerOvarian Neoplasm
AbbVie 1,140
Testing effectiveness (Phase 2)Ended earlyNCT00595985
What this trial is testing

Sorafenib as a Second Line Treatment in Patients With Advanced or Metastatic Gastric Cancer

Who this might be right for
Gastric Cancer
Fudan University 5
Testing effectiveness (Phase 2)Ended earlyNCT03686345
What this trial is testing

Midostaurin Associated With Standard Chemotherapy in Patients With Core-binding Factor Leukemia

Who this might be right for
Core Binding Factor Acute Myeloid Leukemia (CBF-AML)
Niguarda Hospital 34
Post-approval studies (Phase 4)WithdrawnNCT00510627
What this trial is testing

Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Secondary Liver Metastases

Who this might be right for
Metastatic Liver CancerSecondary Liver CancerLiver Neoplasm
Boston Scientific Corporation
Not applicableStudy completedNCT03439332
What this trial is testing

Multicentre Validation of How Vascular Biomarkers From Tumor Can Predict the Survival of the Patient With Glioblastoma

Who this might be right for
Glioblastoma
Juan M Garcia-Gomez 305
Testing effectiveness (Phase 2)Study completedNCT00699881
What this trial is testing

Study of Cetuximab to Treat Gastric Cancer

Who this might be right for
Gastric Cancer
Fudan University 61
Not applicableStudy completedNCT03606616
What this trial is testing

Prospective Feasibility Study Applying the ACOSOG Z0011 Criteria to Chinese Patients

Who this might be right for
Breast CancerSentinel Lymph NodeLocal Recurrence of Malignant Tumor of Breast
Peking University People's Hospital 142
Testing effectiveness (Phase 2)Ended earlyNCT01116128
What this trial is testing

Dasatinib in Combination With Melphalan and Prednisone to Treat Relapsed and Refractory Multiple Myeloma Patients

Who this might be right for
Myeloma
Fondazione EMN Italy Onlus 8
Not applicableEnrolling By InvitationNCT06868095
What this trial is testing

Multi-Center Study Protocol: Impact of Sarcopenia in Early-Onset Colorectal Cancer.

Who this might be right for
Colorectal CancerEarly Onset Colorectal CancerSarcopenia+3 more
Instituto de Investigación Biomédica de Salamanca 1,000
Large-scale testing (Phase 3)Study completedNCT00556712
What this trial is testing

Tarceva (Erlotinib) Following Platinum-Based Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 889
Not applicableUnknownNCT04331912
What this trial is testing

PFS and OS of Patients With Advanced Neuroendocrine Cancer (NEN) After Systemic Treatment

Who this might be right for
Neuroendocrine Tumors
University of Warmia and Mazury 100
Not applicableLooking for participantsNCT07258043
What this trial is testing

Efficacy of Dose-Adjusted Regimen on Survival in Frail Adults With Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphobkastic LeukemiaLeukemiaOverall Survival
Hospital General de Mexico 45
Large-scale testing (Phase 3)Study completedNCT00089479
What this trial is testing

Xeloda (Capecitabine) in Women With High-Risk Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 2,611
Not applicableLooking for participantsNCT05687084
What this trial is testing

Uterine Manipulator Versus no Uterine Manipulator in Endometrial Cancer Trial

Who this might be right for
Endometrial Neoplasms
Universita di Verona 1,030
Not applicableUnknownNCT02002195
What this trial is testing

Modified Folinic Acid-Fluorouracil-Oxaliplatin Regimen + Capecitabine for Elderly With Metastatic Gastric Cancer

Who this might be right for
Metastatic Gastric Cancer
International Group of Endovascular Oncology 47
Large-scale testing (Phase 3)Not Yet RecruitingNCT07068464
What this trial is testing

ICRA Randomised Controlled Trial

Who this might be right for
Ovary Cancer
NHS Grampian 682
Not applicableStudy completedNCT03998332
What this trial is testing

Overall Survival of Large Cell Neuroendocrine Lung Cancer Patients - a Retrospective Study

Who this might be right for
Survival Outcomes of Patients With Pulmonary LCNEC
Jaroslaw B. Cwikla, MD, PhD, Professor UWM 132
Large-scale testing (Phase 3)Study completedNCT00820339
What this trial is testing

Pringle's Maneuver Versus Selective Hepatic Vascular Exclusion in Hepatectomy

Who this might be right for
Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 132
Large-scale testing (Phase 3)Ended earlyNCT02999854
What this trial is testing

Safety and Efficacy of ATIR101 as Adjunctive Treatment to Blood Stem Cell Transplantation From a Haploidentical Family Donor Compared to Post-transplant Cyclophosphamide in Patients With Blood Cancer

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome
Kiadis Pharma 63
Load More Results